| pubmed-article:8316049 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8316049 | lifeskim:mentions | umls-concept:C0032172 | lld:lifeskim |
| pubmed-article:8316049 | lifeskim:mentions | umls-concept:C0450129 | lld:lifeskim |
| pubmed-article:8316049 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:8316049 | lifeskim:mentions | umls-concept:C2348205 | lld:lifeskim |
| pubmed-article:8316049 | lifeskim:mentions | umls-concept:C0205198 | lld:lifeskim |
| pubmed-article:8316049 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8316049 | pubmed:dateCreated | 1993-7-23 | lld:pubmed |
| pubmed-article:8316049 | pubmed:abstractText | Agents which prime the neutrophil NADPH oxidase develop during routine storage of whole blood and packed red blood cells. This plasma priming activity can be inhibited by bepafant (WEB 2170), a specific platelet activating factor (PAF) receptor antagonist. Quantitation of the priming agent(s), by a commercially available radioimmunoassay for PAF, reproducibly demonstrated high levels of PAF activity. However, analysis of these plasma samples from stored blood components by gas chromatography/mass spectroscopy did not reveal any 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine. We conclude that the polyclonal antibody to PAF used in these studies may have recognized different epitopes of a family of heterogeneous, biologically active lipids that manifest their effects through the PAF receptor. | lld:pubmed |
| pubmed-article:8316049 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8316049 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8316049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8316049 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8316049 | pubmed:month | May | lld:pubmed |
| pubmed-article:8316049 | pubmed:issn | 0024-4201 | lld:pubmed |
| pubmed-article:8316049 | pubmed:author | pubmed-author:ClayK LKL | lld:pubmed |
| pubmed-article:8316049 | pubmed:author | pubmed-author:JohnsonC ACA | lld:pubmed |
| pubmed-article:8316049 | pubmed:author | pubmed-author:AmbrusoD RDR | lld:pubmed |
| pubmed-article:8316049 | pubmed:author | pubmed-author:ThurmanG WGW | lld:pubmed |
| pubmed-article:8316049 | pubmed:author | pubmed-author:SillimanC CCC | lld:pubmed |
| pubmed-article:8316049 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8316049 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:8316049 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8316049 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8316049 | pubmed:pagination | 415-8 | lld:pubmed |
| pubmed-article:8316049 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:meshHeading | pubmed-meshheading:8316049-... | lld:pubmed |
| pubmed-article:8316049 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8316049 | pubmed:articleTitle | Compounds biologically similar to platelet activating factor are present in stored blood components. | lld:pubmed |
| pubmed-article:8316049 | pubmed:affiliation | Department of Pediatrics, University of Colorado School of Medicine, Denver. | lld:pubmed |
| pubmed-article:8316049 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8316049 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
